AU2001231053A1 - Lipid metabolism enzymes - Google Patents

Lipid metabolism enzymes

Info

Publication number
AU2001231053A1
AU2001231053A1 AU2001231053A AU3105301A AU2001231053A1 AU 2001231053 A1 AU2001231053 A1 AU 2001231053A1 AU 2001231053 A AU2001231053 A AU 2001231053A AU 3105301 A AU3105301 A AU 3105301A AU 2001231053 A1 AU2001231053 A1 AU 2001231053A1
Authority
AU
Australia
Prior art keywords
lipid metabolism
metabolism enzymes
enzymes
lipid
metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001231053A
Inventor
Yalda Azimzai
Mariah R. Baughn
Ameena R. Gandhi
Jennifer L. Hillman
Dyung Aina M. Lu
Danniel B. Nguyen
Y. Tom Tang
Narinder K. Walia
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001231053A1 publication Critical patent/AU2001231053A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001231053A 2000-01-21 2001-01-18 Lipid metabolism enzymes Abandoned AU2001231053A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US17773200P 2000-01-21 2000-01-21
US60177732 2000-01-21
US17888500P 2000-01-28 2000-01-28
US60178885 2000-01-28
US18186300P 2000-02-11 2000-02-11
US60181863 2000-02-11
US18368300P 2000-02-17 2000-02-17
US60183683 2000-02-17
PCT/US2001/002060 WO2001053468A2 (en) 2000-01-21 2001-01-18 Lipid metabolism enzymes and polynucleotides encoding them

Publications (1)

Publication Number Publication Date
AU2001231053A1 true AU2001231053A1 (en) 2001-07-31

Family

ID=27497246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001231053A Abandoned AU2001231053A1 (en) 2000-01-21 2001-01-18 Lipid metabolism enzymes

Country Status (6)

Country Link
US (1) US20040248243A1 (en)
EP (1) EP1257635A2 (en)
JP (1) JP2003523740A (en)
AU (1) AU2001231053A1 (en)
CA (1) CA2397946A1 (en)
WO (1) WO2001053468A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686185B1 (en) * 2000-03-07 2004-02-03 Millennium Pharmaceuticals, Inc. 25934, a novel fatty acid desaturase and uses therefor
US20040157221A9 (en) * 2000-03-07 2004-08-12 Millennium Pharmaceuticals, Inc. Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
US7049089B2 (en) 2000-05-30 2006-05-23 Bayer Aktiengesellschaft Regulation of human PLC delta-1
US20050003388A1 (en) * 2000-07-18 2005-01-06 Gross Richard W. Calcium independent phospholipase A2upsilon polynucleotides and polypeptides and methods therefor
US6391606B1 (en) 2000-09-14 2002-05-21 Pe Corporation Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
EP1356057A2 (en) * 2000-11-14 2003-10-29 Millennium Pharmaceuticals, Inc. 56634, a novel human phosphatidylinositol 4-phosphate 5-kinase family member and uses thereof
US20030215849A1 (en) 2002-03-01 2003-11-20 Marcia Belvin PDPK1s as modifiers of the p53 pathway and methods of use
WO2006015622A1 (en) * 2004-08-09 2006-02-16 Cellzome Ag Treatment of neurodegenerative diseases by the use of degs inhibitors
CN114158523A (en) * 2021-08-12 2022-03-11 昆明医科大学 Method for establishing improved rabbit abdominal aortic atherosclerotic plaque model

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1073740A4 (en) * 1998-04-29 2002-11-13 Genesis Res & Dev Corp Ltd Polynucleotides isolated from skin cells and methods for their use
AU3730500A (en) * 1999-03-19 2000-10-09 Human Genome Sciences, Inc. 50 human secreted proteins

Also Published As

Publication number Publication date
CA2397946A1 (en) 2001-07-26
US20040248243A1 (en) 2004-12-09
EP1257635A2 (en) 2002-11-20
WO2001053468A2 (en) 2001-07-26
WO2001053468A3 (en) 2002-03-07
JP2003523740A (en) 2003-08-12

Similar Documents

Publication Publication Date Title
AU4211600A (en) Modified lipid production
AU2002216470A1 (en) Cholesterol lowering supplement
AU2001277969A1 (en) Direct internet advertising
AU2001288754A1 (en) Multiple advertising
AU2002357860A1 (en) Enzymes
AU1878601A (en) Enzyme
AU2001247049A1 (en) Autostereoscopic display
AU2001264055A1 (en) Display assembly
AU5101599A (en) Tetrahydrofolate metabolism enzymes
AU2001281636A1 (en) Advertising
AU2001227900A1 (en) Drug metabolizing enzymes
AU2001274981A1 (en) Drug metabolizing enzymes
AU5018900A (en) Lipid metabolism transcription factor
AU2001270303A1 (en) Drug metabolizing enzymes
AU2001231053A1 (en) Lipid metabolism enzymes
AU2002347778A1 (en) Enzymes
AU2001294245A1 (en) Compositions for improving lipid metabolism
AU2001245397A1 (en) Lipid metabolism enzymes
AU2001261424A1 (en) Lipid metabolism enzymes
AU2001273235A1 (en) Lipid metabolism molecules
AU2001255324A1 (en) Drug metabolizing enzymes
AU2001235000A1 (en) Drug metabolizing enzymes
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2001257427A1 (en) Rna metabolism proteins
AU2001278154A1 (en) Drug metabolizing enzymes